For example, glioma cells expressing EGFR variant III (EGFRvIII) secrete these in EVs that are internalised by EGFRvIII negative recipient cell in the tumor to activate MAPkinase and protein kinase B signaling pathways and promote tumor phenotype 37. This evidence concerns the gene EGFR and central nervous system cancer.